These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7378311)

  • 1. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
    Edgar W; Warrell MJ; Warrell DA; Prentice CR
    Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: Haemostatic changes following snake bite by Echis carinatus; trial of heparin.
    Prentice CR; Warrell DA; Forbes CD; Edgar W
    Thromb Diath Haemorrh; 1975 Sep; 34(1):350-1. PubMed ID: 1188797
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo.
    Woodhams BJ; Than T; Than T; Hutton RA
    Br J Haematol; 1989 Jan; 71(1):107-11. PubMed ID: 2492816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria.
    Warrell DA; Davidson NMcD ; Greenwood BM; Ormerod LD; Pope HM; Watkins BJ; Prentice CR
    Q J Med; 1977 Jan; 46(181):33-62. PubMed ID: 866568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Defibrination syndrome after snake bites].
    Meissner A; Hausmann B; Linn C; Piepgras P; Mönig H; Wronski R; Bruhn HD
    Dtsch Med Wochenschr; 1989 Sep; 114(39):1484-7. PubMed ID: 2477208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
    Smith EB
    Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
    Connaghan DG; Francis CW; Lane DA; Marder VJ
    Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms.
    Warrell DA; Davidson NM; Omerod LD; Pope HM; Watkins BJ; Greenwood BM; Ried HA
    Br Med J; 1974 Nov; 4(5942):437-40. PubMed ID: 4154124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction.
    Sørensen JV; Jensen HP; Rahr HB; Borris LC; Lassen MR; Fedders O; Haase JP; Knudsen F
    Haemostasis; 1993; 23(2):91-7. PubMed ID: 8365691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma thrombin assay using a chromogenic substrate in disseminated intravascular coagulation due to snake bite envenomation.
    Herrmann RP; Bailey PE
    Thromb Haemost; 1979 May; 41(3):544-52. PubMed ID: 462421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.